These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7697909)

  • 1. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
    Karussis DM; Vourka-Karussis U; Lehmann D; Abramsky O; Ben-Nun A; Slavin S
    Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation: a new strategy for intractable diseases.
    Ikehara S
    Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice.
    Takeuchi K; Inaba M; Miyashima S; Ogawa R; Ikehara S
    Blood; 1998 Jun; 91(12):4616-23. PubMed ID: 9616158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice.
    Woo J; Wright TM; Lemster B; Borochovitz D; Nalesnik MA; Thomson AW
    Clin Exp Immunol; 1995 Apr; 100(1):118-25. PubMed ID: 7535208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
    Karussis DM; Slavin S; Lehmann D; Mizrachi-Koll R; Abramsky O; Ben-Nun A
    J Immunol; 1992 Mar; 148(6):1693-8. PubMed ID: 1541813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice.
    Wang B; Yamamoto Y; El-Badri NS; Good RA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3012-6. PubMed ID: 10077628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
    Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
    Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for autoimmune diseases.
    Ikehara S
    Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
    Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
    Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
    Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
    Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
    Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
    Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of coronary vascular disease by transplantation of T-cell-depleted bone marrow and hematopoietic stem cell preparation in autoimmune-prone w/BF(1) mice.
    Kirzner RP; Engelman RW; Mizutani H; Specter S; Good RA
    Biol Blood Marrow Transplant; 2000; 6(5):513-22. PubMed ID: 11063380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for BMT, organ transplantation, and regeneration therapy.
    Ikehara S
    Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.
    Levite M; Zinger H; Zisman E; Reisner Y; Mozes E
    Cell Immunol; 1995 Apr; 162(1):138-45. PubMed ID: 7704902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity in mice bearing lprcg: a novel mutant gene.
    Kimura M; Matsuzawa A
    Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL; Himeno K; Tsuru S; Nomoto K
    Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of autoimmune manifestations in MRL/l and MRL/n mice using total lymphoid irradiation (TLI).
    Moscovitch M; Rosenmann E; Neeman Z; Slavin S
    Exp Mol Pathol; 1983 Feb; 38(1):33-47. PubMed ID: 6339270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.